<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">BUILDING BRIDGES FOR INNOVATION IN AGEING : SYNERGIES BETWEEN ACTION GROUPS OF THE EIP ON AHA</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="laboratory">VIMA : Ageing and chronic diseases Epidemiological and public health approaches</orgName>
								<orgName type="institution">INSERM</orgName>
								<address>
									<postCode>U1168</postCode>
									<settlement>Paris</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">UMR-S 1168</orgName>
								<orgName type="institution" key="instit1">UVSQ</orgName>
								<orgName type="institution" key="instit2">Université Versailles St-Quentin-en-Yvelines</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>J , Bewick , M , Cano , A , Eklund , P , Fico , G , Goswami , N , Guldemond , N A , Henderson , D , Hinkema , M J , Liotta , G , Mair</roleName><surname>2017-01 Bousquet</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff22">
								<orgName type="institution">Aragón Aragon Health Sciences Institute (IACS)</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>A , Roller-Wirnsberger , R E , Somekh , D</roleName><surname>Vera-Munoz</surname></persName>
						</author>
						<author>
							<persName><roleName>E , Moda , G , Rodriguez-Manas , L , Vontetsianos , T , Abreu , C</roleName><forename type="first">Manuel</forename><surname>De Keenoy</surname></persName>
						</author>
						<author>
							<persName><roleName>C , Ankri , J , Arredondo , M T , Avolio , F , Bedbrook , A , Bialoszewski , A Z , Blain , H , Bourret , R , Cabrera-Umpierrez , M F , Catala , A , O'Caoimh , R , Cesari , M , Chavannes , N H</roleName><forename type="first">Alonso-Bouzon</forename><surname>Correia-Da-Sousa</surname></persName>
						</author>
						<author>
							<persName><roleName>F , Guerin , O , Hellings , P W , Haahtela , T , Illario , M , Inzerilli , M C , Carlsen , K C L , Kardas , P , Keil , T , Maggio , M , Mendez-Zorrilla , A , Menditto , E , Mercier , J , Michel , J P , Murray , R , Nogues , M</roleName><surname>'byrne-Maguire</surname></persName>
						</author>
						<author>
							<persName><roleName>M , De Carlo , G , Cholley , D , Chorin , F , Combe , B , Compas , B , Costa , D J , Costa , E , Coste , O , Coupet , A -L , Crepaldi , G , Custovic , A , Dahl , R , Dahlen , S E , Demoly , P , Devillier , P , Didier , A , Dinh-Xuan</roleName><forename type="first">D</forename><forename type="middle">'</forename><surname>Angelantonio</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Bewick</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">iQ4U Consultants Ltd</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Cano</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Pediatrics, Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Eklund</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Computing Science Department</orgName>
								<orgName type="institution">Umeå University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">and Four Computing Oy</orgName>
								<address>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Fico</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution">Universidad Politécnica de Madrid (Life Supporting Technologies Research Group)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Goswami</surname></persName>
							<affiliation key="aff10">
								<orgName type="institution">Medical University of Graz</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Guldemond</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Integrated care &amp; technology</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<addrLine>The Netherlands; 10</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">European Innovation Partnership on Active and Healthy Ageing</orgName>
								<orgName type="department" key="dep2">Scottish Centre for Telehealth and Telecare</orgName>
								<orgName type="institution">EIP on AHA</orgName>
								<address>
									<addrLine>Reference Site, NHS 24, 11. TNO</addrLine>
									<settlement>Glasgow, Delft</settlement>
									<country>UK, The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">12. Biomedicine and Prevention Department</orgName>
								<orgName type="institution">University of Tor Vergata</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Henderson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Hinkema</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Liotta</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Mair</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>Molloy</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Monaco</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Monsonis-Paya</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Nizinska</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Papadopoulos</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Pavlickova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Pecorelli</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Prados-Torres</surname></persName>
							<affiliation key="aff22">
								<orgName type="institution">Aragón Aragon Health Sciences Institute (IACS)</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Roller-Wirnsberger</surname></persName>
							<affiliation key="aff10">
								<orgName type="institution">Medical University of Graz</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Somekh</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Vera-Muñoz</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution">Universidad Politécnica de Madrid (Life Supporting Technologies Research Group)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Visser</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Farrell</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Department of Health, Social Services and Public Safety</orgName>
								<orgName type="institution">Northern Ireland Belfast</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Malva</surname></persName>
							<affiliation key="aff24">
								<orgName type="department" key="dep1">Institute of Biomedical Imaging and Life Sciences (IBILI)</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Coimbra</orgName>
								<address>
									<country>Portugal; Ageing</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">K</forename><surname>Andersen Ranberg</surname></persName>
							<affiliation key="aff26">
								<orgName type="institution">Odense University Hospital</orgName>
								<address>
									<addrLine>Region of Southern Denmark; 26</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff27">
								<orgName type="institution">Assitant Director General</orgName>
								<address>
									<settlement>Montpellier</settlement>
								</address>
							</affiliation>
							<affiliation key="aff28">
								<orgName type="institution">Région Languedoc Roussillon-Midi-Pyrénées</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Camuzat</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">European Innovation Partnership on Active and Healthy Ageing Reference Site</orgName>
								<orgName type="institution" key="instit1">MACVIA-LR</orgName>
								<orgName type="institution" key="instit2">Contre les Maladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Carriazo</surname></persName>
							<affiliation key="aff29">
								<orgName type="institution">Regional Ministry of Health of Andalusia</orgName>
								<address>
									<settlement>Seville</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Crooks</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Z</forename><surname>Gutter</surname></persName>
							<affiliation key="aff30">
								<orgName type="institution">University Hospital Olomouc -National eHealth Centre</orgName>
								<address>
									<country key="CZ">Czech Republic</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Iaccarino</surname></persName>
							<affiliation key="aff31">
								<orgName type="department">Depart of Medicine and Surgery</orgName>
								<orgName type="institution">University of Salerno</orgName>
								<address>
									<settlement>Baronissi</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><forename type="middle">Manuel</forename><surname>De Keenoy</surname></persName>
							<affiliation key="aff32">
								<orgName type="department">31. Regione Piemonte</orgName>
								<address>
									<settlement>Kronikgune, Basque Region, Torino</settlement>
									<country>Spain;, Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Moda</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Rodriguez-Mañas</surname></persName>
							<affiliation key="aff33">
								<orgName type="department">Department of Geriatrics</orgName>
								<orgName type="institution">Getafe University Hospital</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Vontetsianos</surname></persName>
							<affiliation key="aff34">
								<orgName type="institution">Sotiria Hospital</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Abreu</surname></persName>
							<affiliation key="aff35">
								<orgName type="institution">Coimbra School of Nursing (Ageing@Coimbra EIP-AHA Reference Site)</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Alonso</surname></persName>
							<affiliation key="aff36">
								<orgName type="institution">IMIM-Institut Hospital del Mar d&apos;Investigacions Mèdiques</orgName>
								<address>
									<addrLine>36. Regionie Puglia</addrLine>
									<settlement>Bari</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Alonso-Bouzon</surname></persName>
							<affiliation key="aff33">
								<orgName type="department">Department of Geriatrics</orgName>
								<orgName type="institution">Getafe University Hospital</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Ankri</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">VIMA : Ageing and chronic diseases Epidemiological and public health approaches</orgName>
								<orgName type="institution">INSERM</orgName>
								<address>
									<postCode>U1168</postCode>
									<settlement>Paris</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">UMR-S 1168</orgName>
								<orgName type="institution" key="instit1">UVSQ</orgName>
								<orgName type="institution" key="instit2">Université Versailles St-Quentin-en-Yvelines</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Arredondo</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution">Universidad Politécnica de Madrid (Life Supporting Technologies Research Group)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Avolio</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Bedbrook</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">European Innovation Partnership on Active and Healthy Ageing Reference Site</orgName>
								<orgName type="institution" key="instit1">MACVIA-LR</orgName>
								<orgName type="institution" key="instit2">Contre les Maladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Wickman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Yorgancioglu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Barbagallo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Canonica</surname></persName>
							<affiliation key="aff79">
								<orgName type="department" key="dep1">82. KLIMEK. Center for Rhinology and Allergology</orgName>
								<orgName type="department" key="dep2">83. Research Director</orgName>
								<orgName type="laboratory">Allergy and Respiratory Diseases Clinic</orgName>
								<orgName type="institution" key="instit1">DIMI</orgName>
								<orgName type="institution" key="instit2">University of Genoa</orgName>
								<orgName type="institution" key="instit3">IRCCS AOU San Martino-IST</orgName>
								<address>
									<settlement>Genoa, Wiesbaden</settlement>
									<country>Italy;, Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff80">
								<orgName type="department">Institute of Neuroscience</orgName>
								<orgName type="institution">CNR Aging Branch</orgName>
								<address>
									<settlement>Padova</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Klimek</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Maggi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>Aberer</surname></persName>
							<affiliation key="aff81">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Medical University of Graz</orgName>
								<address>
									<settlement>Graz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Akdis</surname></persName>
							<affiliation key="aff82">
								<orgName type="laboratory">Swiss Institute of Allergy and Asthma Research (SIAF)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Davos</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Adcock</surname></persName>
							<affiliation key="aff83">
								<orgName type="department">Adcock I. Airways Disease</orgName>
								<orgName type="institution" key="instit1">National Heart &amp; Lung Institute</orgName>
								<orgName type="institution" key="instit2">Imperial College London</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Agache</surname></persName>
							<affiliation key="aff85">
								<orgName type="institution">Transylvania University Brasov</orgName>
								<address>
									<settlement>Brasov</settlement>
									<country key="RO">Romania</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Albera</surname></persName>
							<affiliation key="aff86">
								<orgName type="department">89. Andalusian Agency for Social Services and Dependency</orgName>
								<orgName type="institution" key="instit1">Chest Clinic</orgName>
								<orgName type="institution" key="instit2">Turin University</orgName>
								<address>
									<settlement>Seville</settlement>
									<country>Italy;, Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Alonso-Trujillo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Angel Guarcia</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Pediatrics, Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Annesi-Maesano</surname></persName>
							<affiliation key="aff87">
								<orgName type="department">EPAR U707 INSERM</orgName>
								<orgName type="laboratory">EPAR UMR-S UPMC</orgName>
								<address>
									<addrLine>Paris VI</addrLine>
									<settlement>Paris, Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Apostolo</surname></persName>
							<affiliation key="aff35">
								<orgName type="institution">Coimbra School of Nursing (Ageing@Coimbra EIP-AHA Reference Site)</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Arshad</surname></persName>
							<affiliation key="aff88">
								<orgName type="department" key="dep1">David Hide Asthma and Allergy Research Centre</orgName>
								<orgName type="department" key="dep2">Isle of Wight</orgName>
								<address>
									<addrLine>92. Aviitam</addrLine>
									<settlement>Montpellier</settlement>
									<country>United Kingdom, France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Attalin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Avignon</surname></persName>
							<affiliation key="aff89">
								<orgName type="department">Department of Endocrinology</orgName>
								<orgName type="institution">Montpellier University Hospital</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Bachert</surname></persName>
							<affiliation key="aff90">
								<orgName type="department">ENT Dept</orgName>
								<orgName type="laboratory">Upper Airways Research Laboratory</orgName>
								<orgName type="institution">Ghent University Hospital</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Baroni</surname></persName>
							<affiliation key="aff91">
								<address>
									<settlement>Telbios, Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Bel</surname></persName>
							<affiliation key="aff92">
								<orgName type="department" key="dep1">Department of Respiratory Medicine</orgName>
								<orgName type="department" key="dep2">Academic Medical Center (AMC)</orgName>
								<orgName type="department" key="dep3">Centre for Individualized Medicine</orgName>
								<orgName type="department" key="dep4">Department of Pediatrics</orgName>
								<orgName type="department" key="dep5">Faculty off Medicine</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<addrLine>The Netherlands; 97</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff93">
								<orgName type="institution">LInköping University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Benson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Bescos</surname></persName>
							<affiliation key="aff94">
								<orgName type="department">Department of Pathophysiology and Transplantation</orgName>
								<orgName type="institution" key="instit1">Phillips Research Institute</orgName>
								<orgName type="institution" key="instit2">University of Milan</orgName>
								<orgName type="institution" key="instit3">IRCCS Fondazione Ca&apos;Granda Ospedale Maggiore Policlinico</orgName>
								<address>
									<addrLine>Via F Sforza 35, 100. PNDR</addrLine>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff95">
								<orgName type="institution" key="instit1">Portuguese National Programme for Respiratory Diseases</orgName>
								<orgName type="institution" key="instit2">Faculdade de Medicina de Lisboa</orgName>
								<address>
									<postCode>101</postCode>
									<settlement>Lisbon</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
							<affiliation key="aff96">
								<orgName type="department" key="dep1">Institute of Translational Medicine</orgName>
								<orgName type="department" key="dep2">Institute of Lung Health</orgName>
								<orgName type="department" key="dep3">Department of Infection, Immunity and Inflammation</orgName>
								<orgName type="laboratory">Respiratory Biomedical Unit</orgName>
								<orgName type="institution" key="instit1">Second University of Naples</orgName>
								<orgName type="institution" key="instit2">Italian National Research Council</orgName>
								<orgName type="institution" key="instit3">University Hospitals of Leicester NHS Trust</orgName>
								<address>
									<postCode>102</postCode>
									<settlement>Leicestershire</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff97">
								<orgName type="institution">University of Leicester</orgName>
								<address>
									<postCode>103</postCode>
									<settlement>Leicester</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff98">
								<orgName type="institution">University of Medicine and Pharmacy Victor Babes</orgName>
								<address>
									<settlement>Timisoara</settlement>
									<country>Romania; 104. Bush A</country>
								</address>
							</affiliation>
							<affiliation key="aff99">
								<orgName type="department">Department of Respiratory Diseases</orgName>
								<orgName type="institution">Imperial College and Royal Brompton Hospital</orgName>
								<address>
									<postCode>105</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff100">
								<orgName type="institution">Montpellier University Hospital</orgName>
								<address>
									<postCode>106</postCode>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff101">
								<orgName type="institution" key="instit1">Imperial College London -National Heart and Lung Institute</orgName>
								<orgName type="institution" key="instit2">Royal Brompton Hospital NHS</orgName>
								<address>
									<addrLine>107. Maire, 34, 108.Allergologia</addrLine>
									<settlement>London, Ballaruc les Bains</settlement>
									<country>UK, France</country>
								</address>
							</affiliation>
							<affiliation key="aff102">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution" key="instit1">S Medicina Interna</orgName>
								<orgName type="institution" key="instit2">Hospital Vall d&apos;Hebron</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country>Spain; 109</country>
								</address>
							</affiliation>
							<affiliation key="aff103">
								<orgName type="institution">Oslo University Hospital and University of Oslo</orgName>
								<address>
									<postCode>110</postCode>
									<settlement>Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
							<affiliation key="aff104">
								<orgName type="institution">IRCCS Azienda Ospedaliera Santa Maria Nuova</orgName>
								<address>
									<postCode>111</postCode>
									<settlement>Reggio Emilia</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff105">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Chachava Clinic</orgName>
								<orgName type="institution" key="instit2">David Tvildiani Medical University-AIETI Medical School</orgName>
								<orgName type="institution" key="instit3">Grigol Robakidze University</orgName>
								<address>
									<postCode>112</postCode>
									<settlement>Tbilisi</settlement>
									<region>Georgia</region>
								</address>
							</affiliation>
							<affiliation key="aff106">
								<orgName type="department">113. Imperial College</orgName>
								<orgName type="institution">University CEU San Pablo</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff107">
								<orgName type="institution">National Heart &amp; Lung Institute</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Blasi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Barbara</surname></persName>
						</author>
						<author>
							<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Bergmann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Bernard</surname></persName>
							<affiliation key="aff39">
								<orgName type="institution">University Montpellier</orgName>
								<address>
									<postCode>2991</postCode>
									<settlement>Euromov</settlement>
									<region>EA</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Bonini</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bousquet</surname></persName>
							<affiliation key="aff87">
								<orgName type="department">EPAR U707 INSERM</orgName>
								<orgName type="laboratory">EPAR UMR-S UPMC</orgName>
								<address>
									<addrLine>Paris VI</addrLine>
									<settlement>Paris, Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Branchini</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Brightling</surname></persName>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Bruguière</surname></persName>
							<affiliation key="aff63">
								<orgName type="department">65. AFFINITY</orgName>
								<orgName type="institution">Caisse d&apos;assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR)</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff64">
								<orgName type="institution">State Claims Agency/Health Service Executive</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Bunu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Bush</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Caimmi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Calderon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Canovas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Cardona</surname></persName>
						</author>
						<author>
							<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Carlsen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Cesario</surname></persName>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Chkhartishvili</surname></persName>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Chiron</surname></persName>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Chivato</surname></persName>
						</author>
						<author>
							<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Chung</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>M. D</roleName><surname>'angelantonio</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>De Carlo</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Cholley</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Chorin</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Combe</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Compas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Costa</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">European Innovation Partnership on Active and Healthy Ageing Reference Site</orgName>
								<orgName type="institution" key="instit1">MACVIA-LR</orgName>
								<orgName type="institution" key="instit2">Contre les Maladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Costa</surname></persName>
							<affiliation key="aff22">
								<orgName type="institution">Aragón Aragon Health Sciences Institute (IACS)</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">O</forename><surname>Coste</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A.-L</forename><surname>Coupet</surname></persName>
							<affiliation key="aff63">
								<orgName type="department">65. AFFINITY</orgName>
								<orgName type="institution">Caisse d&apos;assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR)</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff64">
								<orgName type="institution">State Claims Agency/Health Service Executive</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Crepaldi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Custovic</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Department of Health, Social Services and Public Safety</orgName>
								<orgName type="institution">Northern Ireland Belfast</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Dahl</surname></persName>
							<affiliation key="aff24">
								<orgName type="department" key="dep1">Institute of Biomedical Imaging and Life Sciences (IBILI)</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of Coimbra</orgName>
								<address>
									<country>Portugal; Ageing</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Dahlen</surname></persName>
							<affiliation key="aff26">
								<orgName type="institution">Odense University Hospital</orgName>
								<address>
									<addrLine>Region of Southern Denmark; 26</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff27">
								<orgName type="institution">Assitant Director General</orgName>
								<address>
									<settlement>Montpellier</settlement>
								</address>
							</affiliation>
							<affiliation key="aff28">
								<orgName type="institution">Région Languedoc Roussillon-Midi-Pyrénées</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Demoly</surname></persName>
							<affiliation key="aff87">
								<orgName type="department">EPAR U707 INSERM</orgName>
								<orgName type="laboratory">EPAR UMR-S UPMC</orgName>
								<address>
									<addrLine>Paris VI</addrLine>
									<settlement>Paris, Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Devillier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Didier</surname></persName>
							<affiliation key="aff29">
								<orgName type="institution">Regional Ministry of Health of Andalusia</orgName>
								<address>
									<settlement>Seville</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Dinh-Xuan</surname></persName>
							<affiliation key="aff30">
								<orgName type="institution">University Hospital Olomouc -National eHealth Centre</orgName>
								<address>
									<country key="CZ">Czech Republic</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Djukanovic</surname></persName>
							<affiliation key="aff31">
								<orgName type="department">Depart of Medicine and Surgery</orgName>
								<orgName type="institution">University of Salerno</orgName>
								<address>
									<settlement>Baronissi</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Dokic</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff32">
								<orgName type="department">31. Regione Piemonte</orgName>
								<address>
									<settlement>Kronikgune, Basque Region, Torino</settlement>
									<country>Spain;, Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Du Toit</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Dubakiene</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff33">
								<orgName type="department">Department of Geriatrics</orgName>
								<orgName type="institution">Getafe University Hospital</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Dupeyron</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff34">
								<orgName type="institution">Sotiria Hospital</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff39">
								<orgName type="institution">University Montpellier</orgName>
								<address>
									<postCode>2991</postCode>
									<settlement>Euromov</settlement>
									<region>EA</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Emuzyte</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff35">
								<orgName type="institution">Coimbra School of Nursing (Ageing@Coimbra EIP-AHA Reference Site)</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Fiocchi</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff36">
								<orgName type="institution">IMIM-Institut Hospital del Mar d&apos;Investigacions Mèdiques</orgName>
								<address>
									<addrLine>36. Regionie Puglia</addrLine>
									<settlement>Bari</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Wagner</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Fletcher</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff37">
								<orgName type="department">Department of Prevention of Environmental Hazards and Allergology</orgName>
								<orgName type="institution">Medical University of Warsaw</orgName>
								<address>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Fonseca</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff38">
								<orgName type="department">Department of Geriatrics</orgName>
								<orgName type="institution">Montpellier University hospital</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Fougère</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Gamkrelidze</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Directorate of Finance, eHealth &amp; Pharmaceuticals</orgName>
								<orgName type="department" key="dep2">Scottish Government Health Department</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff39">
								<orgName type="institution">University Montpellier</orgName>
								<address>
									<postCode>2991</postCode>
									<settlement>Euromov</settlement>
									<region>EA</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Garces</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Garcia-Aymeric</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff40">
								<orgName type="department">Directeur Général Adjoint</orgName>
								<orgName type="institution">Montpellier University Hospital</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Garcia-Zapirain</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff41">
								<orgName type="institution">Universidad Politecnica de Madrid (Life Supporting Technologies)</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Gemicioğlu</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff42">
								<orgName type="department">43. Gérontopôle de Toulouse</orgName>
								<orgName type="institution">Technical University of Catalonia</orgName>
								<address>
									<postCode>31059</postCode>
									<settlement>Barcelona, Toulouse</settlement>
									<country>Spain;, France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Gouder</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Hellquist-Dahl</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff43">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Hermosilla-Gimeno</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff44">
								<orgName type="department">School of Health Sciences</orgName>
								<orgName type="institution" key="instit1">Life and Health Sciences Research Institute</orgName>
								<orgName type="institution" key="instit2">ICVS</orgName>
								<orgName type="institution" key="instit3">University of Minho</orgName>
								<address>
									<settlement>Braga</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Héve</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff45">
								<orgName type="institution" key="instit1">EUREGHA</orgName>
								<orgName type="institution" key="instit2">European Regional and Local Health Association</orgName>
								<address>
									<settlement>Brussels</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff46">
								<orgName type="institution">University of Edinburgh</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Holland</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff47">
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Humbert</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
							<affiliation key="aff48">
								<orgName type="department">Department of Otorhinolaryngology</orgName>
								<orgName type="institution">Academic Medical Centre</orgName>
								<address>
									<addrLine>Netherlands; 49</addrLine>
									<settlement>Amsterdam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff49">
								<orgName type="department">50. CHRU Nice</orgName>
								<orgName type="institution">Institute of Health Carlos III (HTA Agency)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country>Spain;, France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Hyland</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Johnston</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Just</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff50">
								<orgName type="department">Department of Microbiology and Immunology</orgName>
								<orgName type="laboratory">Laboratory of Clinical Immunology</orgName>
								<orgName type="institution">KU Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Jutel</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff51">
								<orgName type="institution" key="instit1">Skin and Allergy Hospital</orgName>
								<orgName type="institution" key="instit2">Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><forename type="middle">P</forename><surname>Kaidashev</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff52">
								<orgName type="institution">Federico II University Hospital Naples (R&amp;D and DISMET) Naples</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Khaitov</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff53">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution" key="instit1">Community of Sant&apos;Egidio -Long Live the Elderly program</orgName>
								<orgName type="institution" key="instit2">Oslo University Hospital</orgName>
								<address>
									<settlement>Oslo</settlement>
								</address>
							</affiliation>
							<affiliation key="aff54">
								<orgName type="department" key="dep1">Faculty of Medicine</orgName>
								<orgName type="department" key="dep2">Institute of Clinical Medicine</orgName>
								<orgName type="institution">University of Oslo</orgName>
								<address>
									<settlement>Oslo</settlement>
									<country>Norway; 56. First</country>
								</address>
							</affiliation>
							<affiliation key="aff55">
								<orgName type="department">Department of Family Medicine</orgName>
								<orgName type="institution">Medical University of Lodz</orgName>
								<address>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff56">
								<orgName type="department">57. Institute of Social Medicine, Epidemiology and Health Economics</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
							<affiliation key="aff57">
								<orgName type="department">Institute for Clinical Epidemiology and Biometry</orgName>
								<orgName type="institution">University of Wuerzburg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff58">
								<orgName type="department" key="dep1">58. Internal and Geriatric Medicine</orgName>
								<orgName type="department" key="dep2">Department of Clinical and Experimental Medicine</orgName>
								<orgName type="laboratory">Prevention of Disability Lab Geriatric Clinic</orgName>
								<orgName type="institution" key="instit1">University of Parma</orgName>
								<orgName type="institution" key="instit2">Unit University Hospital of Parma</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">O</forename><surname>Kalayci</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Kalyoncu</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>Keijser</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Kerstjens</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Knezović</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff59">
								<orgName type="department">Center of Pharmacoeconomics</orgName>
								<orgName type="institution">University of Deusto</orgName>
								<address>
									<addrLine>60. CIRFF</addrLine>
									<settlement>Bilbao</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff60">
								<orgName type="institution">Federico II University of Naples</orgName>
								<address>
									<settlement>Naples</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Kowalski</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Koppelman</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff61">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Vice President for Research</orgName>
								<orgName type="department" key="dep3">62. Past-President</orgName>
								<orgName type="department" key="dep4">European Union Geriatric Medicine Society and Editor</orgName>
								<orgName type="laboratory">UMR 9214</orgName>
								<orgName type="institution" key="instit1">CHRU, University Montpellier</orgName>
								<orgName type="institution" key="instit2">PhyMedExp</orgName>
								<orgName type="institution" key="instit3">CNRS</orgName>
								<address>
									<postCode>INSERM U1046</postCode>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff62">
								<orgName type="institution">European Geriatric Medicine</orgName>
								<address>
									<settlement>Geneva</settlement>
									<country>Switzerland; 63. NHS Scotland, UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Kotska</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Kovac</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff59">
								<orgName type="department">Center of Pharmacoeconomics</orgName>
								<orgName type="institution">University of Deusto</orgName>
								<address>
									<addrLine>60. CIRFF</addrLine>
									<settlement>Bilbao</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff60">
								<orgName type="institution">Federico II University of Naples</orgName>
								<address>
									<settlement>Naples</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Kull</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Kuna</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Kvedariene</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff63">
								<orgName type="department">65. AFFINITY</orgName>
								<orgName type="institution">Caisse d&apos;assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR)</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff64">
								<orgName type="institution">State Claims Agency/Health Service Executive</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Lepore</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>Macnee</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff65">
								<orgName type="laboratory">AGE Platform Europe</orgName>
								<address>
									<settlement>Brussels</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Maggio</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Magnan</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff66">
								<orgName type="department">Centre of Pneumology</orgName>
								<orgName type="institution">Coimbra University Hospital</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Majer</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff67">
								<orgName type="department">Department of Prevention of Envinronmental Hazards and Allergology</orgName>
								<orgName type="institution">Medical University of Warsaw</orgName>
								<address>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Manning</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Polibienestar Research Institute -University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff68">
								<orgName type="laboratory">Institute for Microelectronics and Microsystems (IMM-CNR) and INNOVAAL (Public-Private Partnership on Active&amp; Healthy Ageing)</orgName>
								<address>
									<settlement>Lecce</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Marcucci</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff69">
								<orgName type="department" key="dep1">Faculty of Sport Sciences and Physical Education</orgName>
								<orgName type="department" key="dep2">71. South East Europe Healthcare/ Integrated Care and Senior Tourism</orgName>
								<orgName type="institution">University of Coimbra (Ageing@Coimbra EIP-AHA Reference Site)</orgName>
								<address>
									<country>Portugal, Portugal;, Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Marti</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Masoli</surname></persName>
							<affiliation key="aff15">
								<orgName type="institution">University College</orgName>
								<address>
									<settlement>Cork</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Melen</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff70">
								<orgName type="department">Center of Quality of Life Research</orgName>
								<orgName type="institution">Vilnius University Public Health Institute</orgName>
							</affiliation>
							<affiliation key="aff71">
								<orgName type="institution">Vilnius University Clinic of Children&apos;s Diseases</orgName>
								<address>
									<settlement>Vilnius</settlement>
									<country key="LT">Lithuania</country>
								</address>
							</affiliation>
							<affiliation key="aff72">
								<orgName type="department" key="dep1">EAP/UEMS-SP)</orgName>
								<orgName type="department" key="dep2">73. European Association of Pediatrics</orgName>
								<orgName type="department" key="dep3">Dept of Chest Medicine</orgName>
								<orgName type="institution" key="instit1">European Academy of Paediatrics</orgName>
								<orgName type="institution" key="instit2">Centre Hospitalier Universitaire Dinant-Godinne</orgName>
								<orgName type="institution" key="instit3">Université Catholique de Louvain</orgName>
								<address>
									<settlement>Yvoir</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Miculinic</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Mihaltan</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Milenkovic</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff73">
								<orgName type="department">Finnish Lung Association; 76. Roessingh Research and Development</orgName>
								<orgName type="institution">FILHA</orgName>
								<address>
									<addrLine>Telemedicine group</addrLine>
									<settlement>Enschede</settlement>
								</address>
							</affiliation>
							<affiliation key="aff74">
								<orgName type="department" key="dep1">Faculty of Electrical Engineering, Mathematics and Computer Science</orgName>
								<orgName type="department" key="dep2">77. Sachs&apos; Children and Youth Hospital</orgName>
								<orgName type="institution" key="instit1">University of Twente</orgName>
								<orgName type="institution" key="instit2">Telemedicine group</orgName>
								<address>
									<settlement>Enschede, Södersjukhuset</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff75">
								<orgName type="institution" key="instit1">Stockholm and Institute of Environmental Medicine</orgName>
								<orgName type="institution" key="instit2">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country>Sweden; 78. A. Celal</country>
								</address>
							</affiliation>
							<affiliation key="aff76">
								<orgName type="department">Department of Pulmonology</orgName>
								<orgName type="institution">Bayar University</orgName>
								<address>
									<settlement>Manisa</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Millot-Keurinck</surname></persName>
							<affiliation key="aff63">
								<orgName type="department">65. AFFINITY</orgName>
								<orgName type="institution">Caisse d&apos;assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR)</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff64">
								<orgName type="institution">State Claims Agency/Health Service Executive</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Mlinarić</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">AIFA -Agenzia Italiana del Farmaco</orgName>
								<address>
									<addrLine>Area strategia e politiche del farmaco</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="institution">Ufficio coordinamento OsMed ed attività HTA</orgName>
								<address>
									<settlement>Roma</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff59">
								<orgName type="department">Center of Pharmacoeconomics</orgName>
								<orgName type="institution">University of Deusto</orgName>
								<address>
									<addrLine>60. CIRFF</addrLine>
									<settlement>Bilbao</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff60">
								<orgName type="institution">Federico II University of Naples</orgName>
								<address>
									<settlement>Naples</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Momas</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Montefort</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Morais-Almeida</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><surname>Moreno-Casbas</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University of Lower Silesia</orgName>
								<address>
									<settlement>Wrocław</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff79">
								<orgName type="department" key="dep1">82. KLIMEK. Center for Rhinology and Allergology</orgName>
								<orgName type="department" key="dep2">83. Research Director</orgName>
								<orgName type="laboratory">Allergy and Respiratory Diseases Clinic</orgName>
								<orgName type="institution" key="instit1">DIMI</orgName>
								<orgName type="institution" key="instit2">University of Genoa</orgName>
								<orgName type="institution" key="instit3">IRCCS AOU San Martino-IST</orgName>
								<address>
									<settlement>Genoa, Wiesbaden</settlement>
									<country>Italy;, Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff80">
								<orgName type="department">Institute of Neuroscience</orgName>
								<orgName type="institution">CNR Aging Branch</orgName>
								<address>
									<settlement>Padova</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Mösges</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Mullol</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Nadif</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">VIMA : Ageing and chronic diseases Epidemiological and public health approaches</orgName>
								<orgName type="institution">INSERM</orgName>
								<address>
									<postCode>U1168</postCode>
									<settlement>Paris</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">UMR-S 1168</orgName>
								<orgName type="institution" key="instit1">UVSQ</orgName>
								<orgName type="institution" key="instit2">Université Versailles St-Quentin-en-Yvelines</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Nalin</surname></persName>
							<affiliation key="aff91">
								<address>
									<settlement>Telbios, Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Navarro-Pardo</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Pediatrics, Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff81">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Medical University of Graz</orgName>
								<address>
									<settlement>Graz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">K</forename><surname>Nekam</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff82">
								<orgName type="laboratory">Swiss Institute of Allergy and Asthma Research (SIAF)</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Davos</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Ninot</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff83">
								<orgName type="department">Adcock I. Airways Disease</orgName>
								<orgName type="institution" key="instit1">National Heart &amp; Lung Institute</orgName>
								<orgName type="institution" key="instit2">Imperial College London</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Paccard</surname></persName>
							<affiliation key="aff63">
								<orgName type="department">65. AFFINITY</orgName>
								<orgName type="institution">Caisse d&apos;assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR)</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff64">
								<orgName type="institution">State Claims Agency/Health Service Executive</orgName>
								<address>
									<settlement>Dublin</settlement>
									<country key="IE">Ireland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Pais</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff85">
								<orgName type="institution">Transylvania University Brasov</orgName>
								<address>
									<settlement>Brasov</settlement>
									<country key="RO">Romania</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Palummeri</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
							<affiliation key="aff86">
								<orgName type="department">89. Andalusian Agency for Social Services and Dependency</orgName>
								<orgName type="institution" key="instit1">Chest Clinic</orgName>
								<orgName type="institution" key="instit2">Turin University</orgName>
								<address>
									<settlement>Seville</settlement>
									<country>Italy;, Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Panzner</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Division of Applied Technologies</orgName>
								<orgName type="institution">National Center for Scientific Research (NCSR) «Demokritos»</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Papadopoulos</surname></persName>
							<affiliation key="aff87">
								<orgName type="department">EPAR U707 INSERM</orgName>
								<orgName type="laboratory">EPAR UMR-S UPMC</orgName>
								<address>
									<addrLine>Paris VI</addrLine>
									<settlement>Paris, Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Papanikolaou</surname></persName>
							<affiliation key="aff88">
								<orgName type="department" key="dep1">David Hide Asthma and Allergy Research Centre</orgName>
								<orgName type="department" key="dep2">Isle of Wight</orgName>
								<address>
									<addrLine>92. Aviitam</addrLine>
									<settlement>Montpellier</settlement>
									<country>United Kingdom, France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Passalacqua</surname></persName>
							<affiliation key="aff79">
								<orgName type="department" key="dep1">82. KLIMEK. Center for Rhinology and Allergology</orgName>
								<orgName type="department" key="dep2">83. Research Director</orgName>
								<orgName type="laboratory">Allergy and Respiratory Diseases Clinic</orgName>
								<orgName type="institution" key="instit1">DIMI</orgName>
								<orgName type="institution" key="instit2">University of Genoa</orgName>
								<orgName type="institution" key="instit3">IRCCS AOU San Martino-IST</orgName>
								<address>
									<settlement>Genoa, Wiesbaden</settlement>
									<country>Italy;, Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff80">
								<orgName type="department">Institute of Neuroscience</orgName>
								<orgName type="institution">CNR Aging Branch</orgName>
								<address>
									<settlement>Padova</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Pastor</surname></persName>
							<affiliation key="aff89">
								<orgName type="department">Department of Endocrinology</orgName>
								<orgName type="institution">Montpellier University Hospital</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Perrot</surname></persName>
							<affiliation key="aff90">
								<orgName type="department">ENT Dept</orgName>
								<orgName type="laboratory">Upper Airways Research Laboratory</orgName>
								<orgName type="institution">Ghent University Hospital</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Plavec</surname></persName>
							<affiliation key="aff91">
								<address>
									<settlement>Telbios, Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Popov</surname></persName>
							<affiliation key="aff92">
								<orgName type="department" key="dep1">Department of Respiratory Medicine</orgName>
								<orgName type="department" key="dep2">Academic Medical Center (AMC)</orgName>
								<orgName type="department" key="dep3">Centre for Individualized Medicine</orgName>
								<orgName type="department" key="dep4">Department of Pediatrics</orgName>
								<orgName type="department" key="dep5">Faculty off Medicine</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<addrLine>The Netherlands; 97</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff93">
								<orgName type="institution">LInköping University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Postma</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<address>
									<settlement>Baroni, Bel, Benson, Bescos, Barbara, Bergmann, Bernard, Bonini, Bousquet, Branchini, Brightling, Bruguiere, Bunu, Caimmi, Calderon, Canovas, Cardona, Carlsen</settlement>
									<region>E, M, C, Blasi, F, C, K C, P L, S, P J, B, C E, V, C, Bush, A, D P, M A, G, V</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="institution">University of Brescia</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="institution">Coimbra EIP-AHA Reference Site</orgName>
								<address>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff77">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff78">
								<orgName type="department">Department of Internal Medicine (DIBIMIS)</orgName>
								<orgName type="institution" key="instit1">Geriatric Unit</orgName>
								<orgName type="institution" key="instit2">University of Palermo</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff84">
								<orgName type="laboratory">Biomedical Research Unit</orgName>
								<orgName type="institution">Royal Brompton &amp; Harefield NHS Trust</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">BUILDING BRIDGES FOR INNOVATION IN AGEING : SYNERGIES BETWEEN ACTION GROUPS OF THE EIP ON AHA</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">ADC843004639A73936C459D409B1A7A4</idno>
					<note type="submission">Received April 10, 2016 Accepted for publication April 12, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:10+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The European Commission aims to enhance European competitiveness and tackle societal challenges through research and innovation (European Innovation Partnerships (EIP).</s><s>Active and Healthy Ageing (AHA) is a major health and societal challenge in all European countries, and an area with considerable potential for European leadership.</s><s>An initiative was therefore launched by the EIP on AHA to accomplish a triple win (1): • Enabling citizens to lead healthy, active and independent lives while ageing.</s><s>• Improving the sustainability and efficiency of social and health care systems.</s><s>• Boosting and improving the competitiveness of the markets for innovative products and services responding to the ageing challenge.</s></p><p><s>The EIP on AHA programme framework defined priority areas of work translated into six specific Action Groups (AG).</s><s>Over 500 commitments were submitted from organisations (Table <ref type="table">1</ref>) and 32 Reference Sites were recognised in July 2013 as excellence sites for innovation in AHA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Aim of the Task Force on synergies</head><p><s>The EIP on AHA requires a multidimensional and multidisciplinary approach.</s><s>After three years of collaboration and activities, many achievements have been obtained.</s><s>However, AGs have often worked in silos.</s><s>Now that AGs have Abstract: The Strategic Implementation Plan of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) proposed six Action Groups.</s><s>After almost three years of activity, many achievements have been obtained through commitments or collaborative work of the Action Groups.</s><s>However, they have often worked in silos and, consequently, synergies between Action Groups have been proposed to strengthen the triple win of the EIP on AHA.</s><s>The paper presents the methodology and current status of the Task Force on EIP on AHA synergies.</s><s>Synergies are in line with the Action Groups' new Renovated Action <ref type="bibr">Plan (2016</ref><ref type="bibr">Plan ( -2018) )</ref> to ensure that their future objectives are coherent and fully connected.</s><s>The outcomes and impact of synergies are using the Monitoring and Assessment Framework for the EIP on AHA (MAFEIP).</s><s>Eight proposals for synergies have been approved by the Task Force: Five cross-cutting synergies which can be used for all current and future synergies as they consider overarching domains (appropriate polypharmacy, citizen empowerment, teaching and coaching on AHA, deployment of synergies to EU regions, Responsible Research and Innovation), and three cross-cutting synergies focussing on current Action Group activities (falls, frailty, integrated care and chronic respiratory diseases).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Terminology used in the paper</head><p><s>Organisations can participate in the EIP on AHA using: • Individual commitments: Individual task of an AG.</s><s>• Collaborative work: Project agreed by an AG and carried out by several organisations.</s><s>Results are tangible outcomes from commitments and/or collaborative work (e.g. a report, a completed pilot study, a guideline, etc.).</s><s>They have to be specific, measurable, achievable and time-bound.</s></p><p><s>Synergies (defined by the Synergy TF in coordination with AGs): Commitments and/or collaborative work with cross-cutting interest and relevance to several AGs.</s><s>They were established using a concerted approach.</s><s>A synergy should be in line with the individual AG's Renovated Action Plan.</s></p><p><s>Collaborative work and Synergies can be managed on a voluntary basis following the objectives set or in a more agile way using SPRINTS that are proposed using a specific template with defined short-term results reported every 6 months.</s><s>In software product development, a sprint is a set period of time during which specific work has to be completed (http://searchsoftwarequality.techtarget.com/definition/Scrum-sprint).</s><s>matured, more attention can be given to collaboration across AGs for topics with a shared interest.</s></p><p><s>In the next phase of the EIP on AHA programme, synergies will be initiated for a practical, action-oriented contribution to a common framework to further strengthen the EIP on AHA triple win.</s></p><p><s>More specifically, the aims of the TF are to: 1-Outline the methodology and current status of the EIP on AHA synergies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methodology used by the Task Force to develop synergies</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Selection of task force members</head><p><s>A TF was set up to identify synergies, and to describe and evaluate them.</s><s>Initially, each AG selected at least 2 members.</s><s>Members of the PROEIPAHA Coordination and Support Action and the AG promoters were also invited to participate in the TF. .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Template to develop proposals for synergies</head><p><s>Synergies were based on a common 4-page template that was unanimously agreed upon by all the TF members (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment of proposals</head><p><s>A transparent methodology was developed to evaluate the synergies on relevance, quality and applicability.</s><s>The templates were evaluated by two members from each AG based on a set of criteria checked through Survey Monkey (Figure <ref type="figure" target="#fig_1">1</ref>) (www.</s><s>surveymonkey.com).</s><s>All proposals with a threshold mean level of 6/10 or above for all the 9 criteria were approved (a unanimous decision was required).</s><s>The inter-rater variance was low between assessments.</s><s>Proposals that did not reach the threshold level were revised and further approved.</s><s>Finally, 8 proposals were accepted and one was withdrawn.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Type of synergies</head><p><s>Two types of complementary cross-cutting synergies were submitted (Figure <ref type="figure">2</ref>): • Synergies considered overarching as they address topics that are relevant for most or all AGs • Cross-cutting synergies focussing on a current AG activity which will be deployed to other AGs</s></p><p><s>The 8 synergies are detailed in the online supplement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 2 Synergies of the EIP on AHA</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Activities of the Proposed Synergies</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Overarching synergies</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Information technology and adherence in an ageing population with chronic diseases and appropriate polypharmacy</head><p><s>Leading AG: A1 Rationale: Multimorbidity leads to multiple medications (polypharmacy), increasing the risk of drug interactions, poor treatment adherence and adverse drug reactions (ADR).</s><s>Failure to adhere to medical treatment increases therapeutic failure <ref type="bibr" target="#b19">(5)</ref>, causes unnecessary complications (6) and increases hospitalization and healthcare costs <ref type="bibr" target="#b21">(7)</ref>.</s></p><p><s>General objectives: To increase the adherence to treatment of seniors with chronic diseases and polypharmacy (i) assessing the role of ICT-based solutions and (ii) implementing tailored ICT-based interventions.</s></p><p><s>Specific objectives 1-To study if the application of progressive ICT systems that connect patients with health care professionals can boost the adherence of seniors in long-term therapies and polypharmacy, also considering pharmacists.</s><s>Results from running pilots in the EU will be used for deployment.</s><s>2-To study the role of integrated information systems connecting all stakeholders (e.g.</s><s>patients, family members, health and social carers, and members of municipalities, hospitals, social care entities).</s><s>Results from a running pilot in the EU will be used for deployment.</s><s>Contribution to the Scaling Up Strategy of the EIP on AHA: The study intends to exploit results from many EU countries.</s></p><p><s>Expected Outcomes / Contribution to MAFEIP 1-Impact on QOL: Increased adherence of seniors to medical plans will promote healthier ageing and QOL while reducing complications.</s><s>2-Increased adherence to medical plans will impact the sustainability of the healthcare systems.</s><s>Specific metrics used in the study are currently being defined.</s><s>3-Impact on Economic, Growth and Jobs for both the pharmaceutical industry and in the area of home care technologies and services.</s><s>Opportunities for the development and production of new advanced products are expected to be generated leading to the requirement of more qualified jobs for the new services.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Citizen and patient empowerment</head><p><s>Leading AG: B3, Action Area 6 Rationale: Nearly all the Action Plans launched in 2012 refer to patient or citizen empowerment.</s><s>An active involvement of patients in their interaction with health and social professionals increases care effectiveness and efficiency.</s><s>Citizen empowerment and the facilitating role of ICT are key topics in the EU H2020 programme.</s><s>However, the work done in the EIP on AHA has shown divergent understanding of citizen empowerment, defined in terms of education, joint decisionmaking and self-management.</s><s>Tools such as measures of health literacy and the capacity of individuals or groups for selfmanagement in chronic conditions would be of considerable value in reducing social inequalities.</s></p><p><s>General objectives: To achieve a common understanding of citizen and patient empowerment, and to implement and scaleup good practices.</s></p><p><s>Specific objectives 1-Develop a consensus view of citizen and patient empowerment across the different AGs.</s></p><p><s>2-Share and align citizen empowerment-related activities within and across AGs.</s><s>3-Formulate a set of broad holistic actions, based on a common understanding, to facilitate the scaling-up of good and effective practices via transverse (Synergies TF) as well as vertical processes (AGs) that support the overall objectives of the EIP on AHA.</s><s>4-Scale-up good practices and disseminate knowledge via the Synergies TF, the AGs, the Reference Sites and relevant EU and national initiatives.</s></p><p><s>Contribution to the Scaling Up Strategy of the EIP on AHA: How many regions?</s></p><p><s>All EIP on AHA partners and regions will be involved in this synergy.</s><s>Additionally, all Reference Sites in the Reference Site Collaborative Network (RSCN) will be invited to participate.</s></p><p><s>Expected Outcomes / Contribution to MAFEIP: "Patients with chronic conditions are often referred to as the most underused resource in the health system while patient-centred care models have demonstrated better quality of care as well as potential long-term cost-efficiencies.</s><s>Too many patients are still struggling to get the support they need to become equal partners in care.</s><s>To make real progress, we need to make patient empowerment a priority, starting with the development of an EU-wide strategy and action plan" 1. Impact on QOL with an adequate social network and sufficient empowerment (8-11).</s><s>2. Empowerment of patients and citizens is seen as a key aspect in maintaining health and care systems sustainable (12, 13).</s><s>3. Empowered citizens are more self-sustaining and economically productive <ref type="bibr" target="#b28">(14,</ref><ref type="bibr" target="#b29">15)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Masters of AHA educating seniors, health and social carers and entrepreneurs</head><p><s>Leading AG: A2 Rationale: Integrated, interdisciplinary and inter-professional education for all stakeholders is needed to tackle the interrelated syndrome of frailty, malnutrition, falls, chronic diseases, and their social consequences.</s></p><p><s>General objectives: Development of an innovative, dynamic and sustainable care system for AHA by capacity building through senior/patient-centred, multidisciplinary and interprofessional educational programmes aimed at patients, patient caregivers (both formal and informal), health and social carers, administrators and entrepreneurs.</s></p><p><s>Specific objectives: 1-Multi-professional education to improve the links between all stakeholders through better understanding of the knowledge and competencies of each stakeholder.</s><s>2-Master of Gerontology and Geriatrics: To develop dynamic and sustainable care systems that will encompass interdisciplinary, inter-professional education (IPE) and learning (IPL) including RRI business models.</s><s>3-Best evidence holistic perspective to bring together research, practice, policies and market by courses in medical, nursing, pharmacy, social, behavioural, psychological, economic physiological, management service aspects related to the prevention and management of ageing and using the innovation loop of planning up-scaling strategies.</s><s>4-To promote AHA as well as the empowerment of self-care and (care) independency, by placing the older person at the centre of care.</s><s>Contribution to the Scaling Up Strategy of the EIP on AHA: The programme will be started at the Medical University of Graz, Austria by a well-defined Master of Gerontology and Geriatrics.</s><s>The course will be in English and the teachers and participants will be from different institutions in Europe.</s><s>This programme will be a pilot for other European programmes.</s><s>The multi-professional approach will be developed in collaboration with the European Interdisciplinary Council on Ageing (EICA) gathering professionals from all disciplines interested in AHA and also implementing knowledge transfer to political, economic and lay stakeholders in the field.</s></p><p><s>Regions to be included: Regions will have a role for contributors, sharing their experiences and best practices, as well as for learners.</s><s>Some examples of education programmes carried out in other regions are given in Table <ref type="table" target="#tab_2">3</ref>.</s></p><p><s>Efficient running of the programme: A scientific advisory committee is elaborating a landscape of educational events (homepage of the Medical University of Graz/Austria).</s><s>Experts in the field of AHA will set up quality standards for live or long-distance educational events in the field of AHA (e-learning).</s><s>The committee is composed of members from all stakeholders involved in AHA across Europe.</s><s>The committee will work closely with the members of the RRI framework to ensure evidence-based multi-professional education and to deliver educational research results.</s></p><p><s>Expected Outcomes / Contribution to MAFEIP 1-Impact on the QOL of seniors 2-Ensure health promotion, literacy, engagement and empowerment of senior citizens in aspects related to adopting interventions and life styles that promote active and health ageing (e.g.</s><s>acceptance of evidence-based interventions, behavioural changes towards AHA).</s><s>3-Impact on the Sustainability of Health and Care Systems 4-Impact on Economic, Growth and Jobs</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AHA in the framework of Responsible Research and Innovation (RRI)</head><p><s>Leading AG: D4 Rationale: Responsible Research and Innovation (RRI) is an approach anticipating and assessing potential implications and societal expectations of research and innovation <ref type="bibr" target="#b33">(19,</ref><ref type="bibr" target="#b34">20)</ref>.</s><s>RRI allows all stakeholders involved in research and innovation (i) to obtain relevant knowledge on the consequences of the outcomes of their actions, (ii) to effectively evaluate outcomes in terms of societal needs and moral values and (iii) to use these considerations for the design and development of new research, products and services <ref type="bibr" target="#b33">(19)</ref>.</s><s>The concept in Europe considers eight key areas <ref type="bibr" target="#b35">(21)</ref> that should be included in the dialogue among the different AGs of the EIP on AHA: Governance, Public Engagement, Gender Equality, Science Education, Open Science/Open access, Ethics, Sustainability and Social Justice/ Inclusion.</s></p><p><s>General objectives: To provide a roadmap of actions to be undertaken to promote RRI in AHA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Specific objectives:</head><p><s>1-To identify the current state of the actions and initiatives related to the concept of RRI in the AHA framework and the concrete contribution of the partners and AGs.</s><s>2-To create a group of partners interested in working in this area and to identfy the most urgent actions and the plan of execution for RRI in AHA for the following years.</s><s>3-To analyse the work done in AHA in terms of RRI in the framework of the EIP on AHA and other related networks.</s><s>4-To provide a roadmap of urgent actions to be undertaken in RRI for AHA.</s></p><p><s>Contribution to the Scaling Up Strategy of the EIP on AHA: The synergy considers the engagement of higher numbers and more diverse stakeholders involved in the chain supply of active and healthy ageing products and services.</s><s>These would include grass-root stakeholders (at local and regional level) with no possibility to join the EIP on AHA in Brussels due to economic, linguistic or time limitations and would enable the promotion of a richer dialogue and collaboration.</s><s>The D4 partners/coordinators suggested the consideration of new agents as actors participating in AHA promotion at early stages and other actors supporting innovative ways of promoting active seniors i.e., schools, volunteers, touristic operators, social entrepreneurs.</s></p><p><s>Expected Outcomes / Contribution to MAFEIP: Integration of the concept of RRI to AHA is lacking.</s><s>This synergy will create a baseline for future development and the integration of this trend in a structured and holistic way with the support of relevant stakeholders.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Maturity Model for Integrated Care</head><p><s>Leading AG: B3, Action Area 7 Rationale: Scaling up of EIP on AHA good practices in integrated care to EU regions is essential to reduce health, gender and social inequities in Europe.</s></p><p><s>General objectives: The B3 AG has developed the B3 Maturity Model to assist regions with their efforts to deploy integrated care in Europe in order (i) to reveal the strengths and weaknesses of European regions, (ii) to match those with similar problems and environments to work together and (iii) to help regions scale up their activities.</s></p><p><s>Specific objectives 1.</s><s>To share learning and expertise gained during the development of the B3 Maturity Model 2. To adjust the Maturity Model to address challenges of ageing in Europe such as adherence, frailty, falls prevention and assisted living solutions.</s><s>3. To develop self-assessment tool(s) to assess the readiness of regions in the implementation of solutions for AHA. 4. To test and validate the Maturity Model as a tool for supporting the scaling up and replication of innovative solutions; and facilitating knowledge transfer and exchange of good practices in Europe.</s></p><p><s>Contribution to the Scaling Up Strategy of the EIP on AHA: Aiming to conduct self-assessment in 8 regions, with twinning and coaching activities facilitated by B3 regions.</s></p><p><s>Expected Outcomes / Contribution to MAFEIP 1-Scaling up effective integrated care will improve the quality of care, health and wellbeing of citizens.</s><s>2-Positioning of European regions in terms of strengths and weaknesses will inform national, regional and local authorities about their "future direction of travel" -quick and systematic identification of areas that need attention to achieve improvement in AHA solutions.</s><s>3-Integration of health and care will lead to new roles and competencies for the workforce, and will generate opportunities for growth through scaling up of effective models of care / solutions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cross-cutting synergies focussed on an Action Group</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Falls prevention and injuries: a grand societal challenge</head><p><s>Leading AG: A2 Rationale: Falls represent a major cause of burden and death in seniors <ref type="bibr" target="#b36">(22)</ref>.</s><s>Approximately 30% of falls result in an injury that requires medical attention.</s><s>Fractures occur in approximately 5% of falls and hip fractures in 1% <ref type="bibr" target="#b38">(23)</ref><ref type="bibr" target="#b39">(24)</ref><ref type="bibr" target="#b40">(25)</ref><ref type="bibr" target="#b41">(26)</ref>.</s><s>Falls-related injuries account for over 5% of the medical expenditures in seniors.</s><s>Falls are the third leading cause of years lived with disability.</s></p><p><s>General objectives: To scale up a falls prevention and injuries initiative from local pilot studies to a practical and feasible pan-European programme including all stakeholders.</s></p><p><s>Specific objectives 1-Enable macro-, meso-and micro-level analysis including governance and policy-making based on screening, prevention, rehabilitation and monitoring, as well as an integration with the Silver Economy, and related to WHO's consultation on Global Strategy and Action Plan on Ageing and Health.</s><s>2-Engage regional and municipal levels in fall prevention campaigns, thereby enabling and promoting early frailty and fall risk assessment, and identifying frail and faller profiles.</s><s>3-Anticipate and identify the data analytic scope for health outcome studies in order to utilize the infrastructure and support the widest possible variety of health and social studies, including support for further methods and care service developments related to frailty and fall injury intervention and prevention.</s><s>4-Raise awareness and promote behavioural change among citizens in the prevention of frailty and fall injuries including post-operative interventions.</s><s>5-Understand falls-risk-increasing drugs and frailty.</s><s>6-Provision of specific smart home and smart building oriented ICT solutions viewed from a socio-economic Key Performance Index perspective.</s></p><p><s>Contribution to the Scaling Up Strategy of the EIP on AHA: How many regions?: Five to ten demonstrator regions are proposed, including Austria/Steiermark, Finland, France/ Languedoc-Roussillon, Ireland, Scotland, Spain (Region of Madrid-Getafe University Hospital and Basque country).</s><s>Austria, Finland and France have agreed.</s><s>Discussions are ongoing with others.</s></p><p><s>Expected Outcomes / Contribution to MAFEIP: Scalingup of good practices with an extended MAFEIP monitoring framework (2, 3) including socio-economic and macroeconomic aspects.</s><s>1-Fall risk assessment is often embedded into a broader scope of geriatric assessment, e.g.</s><s>including cognitive and noncognitive aspects of dementia, activities of daily life (ADL), QOL, depression and nutrition.</s><s>EQ5D is often used but is not sufficient for a broader scope of assessment.</s><s>Finer granularity is needed.</s><s>2-Pathways and care processes are important ingredients in sustainability.</s><s>This process of sustainability is discussed within the AG.</s><s>3-Impact on Growth and Jobs: The AG is discussing the whole ecosystem, from both topdown and bottom up approaches.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Impact of the Community-based Programme on Frailty Prevention and frailty Mitigation (ICP -FPM)</head><p><s>Leading AG: A3 Rationale: Prevention, screening, early identification and diagnosis of frailty and functional decline are closely related with the integrated care of chronic diseases.</s><s>They operate primarily in the community, requiring the integration of health (primary, secondary) and social care to deliver screening, targeted assessment (e.g.</s><s>Comprehensive Geriatric Assessment) and evidence-based, cost effective and tailored interventions <ref type="bibr" target="#b42">(27)</ref><ref type="bibr" target="#b43">(28)</ref><ref type="bibr" target="#b44">(29)</ref><ref type="bibr" target="#b45">(30)</ref>.</s><s>This comprehensive approach aims to prevent disability, recurrent hospitalizations, institutionalization and related heath-social care costs <ref type="bibr" target="#b42">(27,</ref><ref type="bibr" target="#b46">31,</ref><ref type="bibr" target="#b47">32)</ref>.</s><s>Interventions must integrate health care and a supportive social environment for the patient and caregiver <ref type="bibr" target="#b48">(33,</ref><ref type="bibr" target="#b49">34)</ref>.</s><s>Women may be at higher rates of physical and cognitive frailty and interventions must be gender and cultural sensitive.</s></p><p><s>General Objective: To set up a public health approach • To prevent, identify and manage frailty in community dwelling older adults, to be validated in different EU member states, • To identify the factors that can be targeted in order to, delay or postpone further decline and disability.</s></p><p><s>Specific objectives 1.</s><s>To join systematic frailty assessment with good practices in frailty prevention and management, by counteracting social isolation, and improving nutrition, adherence to therapy and physical activity.</s><s>2. To promote the continuum of care by integrating social and health care at primary, secondary and tertiary levels.</s><s>3. To assess the impact of this public health model to manage frailty in the community in terms of cost effectiveness, use of health services, acceptance by citizens and patients' QOL. 4. To test the relation between a set of indicators and the prevalence of frailty. 5. To exploit existing ICT-supported assessment and intervention tools.</s><s>6.</s><s>To describe the weaknesses and strengths of caregiver networks, and implement strategies to maintain, supplement and improve this network.</s><s>services needs an increased number of dedicated personnel with potential benefit for the employment levels.</s><s>4-Some markers of the availability of socio-economic resources will also be assessed for their impact on frailty because of their strong relation with mortality rate and an increased use of health resources such as hospitalization and institutionalizations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Multimorbidity of chronic respiratory diseases in seniors: an under-recognised societal problem (B3)</head><p><s>Leading AG: B3, Action Area 5 Rationale: Chronic Respiratory Diseases (CRD) are major chronic diseases.</s><s>Some occur early in life (e.g.</s><s>asthma-rhinitis) and persist throughout life <ref type="bibr" target="#b51">(35,</ref><ref type="bibr" target="#b52">36)</ref>.</s><s>COPD is associated with frailty in seniors (multimorbidity, polymedication).</s><s>CRDs are intertwined with ageing and negatively impact AHA.</s><s>The prevention and control of CRD in the ageing population is vital.</s><s>Integrated care pathways have been set up for CRDs (AIRWAYS ICPs) in the B3 AG <ref type="bibr" target="#b53">(37)</ref><ref type="bibr" target="#b54">(38)</ref><ref type="bibr" target="#b55">(39)</ref>.</s></p><p><s>General objectives: To better understand, prevent, detect and manage CRDs in elderly people, and to assess the impact of their socio-economic and health services utilization.</s><s>Simple ICT tools allowing individualised medication should be developed.</s><s>To raise the awareness of the role of CRDs in the elderly, and advocate for a European strategy, in order to support the scaling up of regional interventions.</s><s>A stepwise action plan is proposed including scientific societies and the involvement of patient's organisations.</s><s>3-Fit at work with rhinitis will have a major impact on economy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Embedding synergies in EIP on AHA Reference Sites</head><p><s>Synergies have been built among EIP on AHA Reference Sites as examples of comprehensive, innovation-based approaches to AHA.</s><s>EIP on AHA Reference Sites are coalitions of regions, cities, integrated hospitals or care organisations able to show a concrete impact of innovative practices, which could be transferred to other European contexts.</s><s>A total of 32 Reference Sites have been awarded (1).</s></p><p><s>Reference Sites conscious of the need for synergies and a collaborative approach to address health and care challenges of an ageing population expressed the common will to establish a Collaborative Network to facilitate joint reflection and action in sharing and transferring best practice in the development and scaling up of health and care strategies, policies and service delivery models.</s></p><p><s>The interregional Reference Site Collaborative Network (RSCN) includes References Sites recognised by the Commission as well as Regions intending to apply for Reference Site status (candidate Reference Sites).</s><s>Its main goal is to improve health and care through an active cooperation, contributing to the general debate with the EU institutions, in order to optimise the possibilities for sharing a strong, sustainable health and care system for all, while respecting the different competences and responsibilities in the direct organisation of the health and care services of the Member States and Regions.</s><s>and classifications is also important.</s><s>WHO classifications are logically lative <ref type="bibr" target="#b76">(59)</ref>.</s><s>The reference classifications ICD (International Classification of Diseases) and ICF (International Classification of Functioning, Disability and Health) then appear in structured relation with each other.</s><s>Similar transformations can be made for the derived and related classifications ICPC-2, ICECI, ISO9999, ATC/DDD and ICNP <ref type="bibr" target="#b77">(60)</ref>.</s></p><p><s>These information entities are inherently multivalent, and classifications like the ICF explicitly recognize this multivalence through introduction of its generic scale.</s><s>This, in turn, requires the formal management of many-valuedness and uncertainty in a logical setting <ref type="bibr" target="#b65">(49)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>AHA requires a multidimensional and multidisciplinary approach to allow people from multiple backgrounds to work together sharing a common language.</s><s>The experience of different stakeholders working in a collaborative way producing concrete results in the different Action Groups sets a promising ground for the difficult challenge of scaling up good practices at European level.</s></p><p><s>The added value of working together requires identifying synergies not only between different good practices but also between different Action Groups result.</s><s>To yield actual benefits, they have to be developed in concrete action plans that explain the rationale for the synergy, the participants, the objectives and a concrete plan with sprints.</s></p><p><s>EIP AHA implementation can manage a limited number of synergy actions.</s><s>To select them, a flexible but structured process, with a transparent evaluation methodology, had to be used.</s><s>The success of the first call, with nine proposals submitted and evaluated, supports the viability of the approach chosen.</s><s>Eight of the proposals were selected.</s></p><p><s>New stakeholders have to join and new proposals need to be implemented.</s><s>To ensure the added value of the whole process, Actions have to be assessed according to their estimated health and economic outcomes as well as health and social care utilisation using MAFEIP and other tools.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Key words :</head><label>words</label><figDesc><div><p><s>Abbreviations: AG: Action Group; AHA: Active and Healthy Ageing; CoP: Conference of Partners; CRD: Chronic Respiratory Diseases; EICA: European Interdisciplinary Council on Ageing; EIP on AHA: European Innovation Partnership on Active and Healthy Ageing; EU: European Union; ICT: Information and Communication Technology; MACVIA-LR: Reference Site Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon; MAFEIP: Monitoring and Assessment Framework for the EIP on AHA; PROEIPAHA: Support Action to the EIP on AHA; QALY: Quality-Adjusted-Life-Years; QOL: Quality of life; RAP: Renovated Action Plan; RRI: Responsible Research and Innovation; RSCN: Reference Site Collaborative Network; TF: Task Force; WHO: World Health Organization; WHODAS 2.0: World Health Organization Disability Assessment Schedule 2.0</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1Survey Monkey evaluation of proposed synergies</s></p></div></figDesc><graphic coords="6,304.96,265.61,257.40,198.99" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>3 -</head><label>3</label><figDesc><div><p><s>To review best practices and available literature to assess whether ICT-based applications that support training, patient empowerment and social interactions can change the behaviour and increase the adherence of seniors to treatment.</s><s>4-To use the lessons learnt in Italy by a National plan for Adherence involving the Italian Medicines Agency (AIFA), the national federation of general practitionners (FIMMG), Geriatrics and Patients associations (in particular Federanziani) and universities.</s><s>The barriers and results of this network can be used to develop or scale up innovative approaches at the EU level.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>2-Align with the AG Renovated Action Plan (RAP).</s><s>3-Evaluate the progress, results and impacts of the synergies with MAFEIP (Monitoring and Assessment Framework for the EIP on AHA) (2, 3).</s><s>4-Support the existing EIP on AHA Scaling Up Strategy</s></p></div></figDesc><table /><note><p><s>(https://ec.europa.eu/research/innovation-union/pdf/activehealthy-ageing/scaling_up_strategy.pdf)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 Template used to submit synergies 1. Title of the proposal</head><label>2</label><figDesc></figDesc><table><row><cell cols="2">2. Leading organisation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">3. Supporting organisations</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">4. Action groups</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>A1</cell><cell>A2</cell><cell>A3</cell><cell>B3</cell><cell>C2</cell><cell>D4</cell></row><row><cell cols="2">AG initiating the proposal</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">AG already involved</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">AG to be contacted</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">5. Rationale for the synergy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">6. Achievements of the EIP on AHA AG</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>7. Objectives</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">• General objectives</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">• Specific objectives</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">8. Concrete plan</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">9. SPRINTS (2016-2017)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>N°</cell><cell>Name</cell><cell>AG</cell><cell>Starting date</cell><cell>Delivery date</cell><cell>Geographical distribution</cell><cell>Results</cell></row><row><cell>S1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>S2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">10. Associated EU programmes</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">11. Alignment with the EIP on AHA objectives</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">12. Resources currently available for the projects</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">13. Expected impact</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Examples of Masters of Gerontology and Geriatrics in Europe</s></p></div></figDesc><table><row><cell>Country</cell><cell>Region or Reference site</cell><cell>Website</cell><cell>Title</cell><cell>Language</cell></row><row><cell>Austria</cell><cell>Graz Medical University</cell><cell></cell><cell>Master of Gerontology and Geria-</cell><cell>English</cell></row><row><cell></cell><cell></cell><cell></cell><cell>trics</cell><cell></cell></row><row><cell>Austria</cell><cell>Medical Doctors' Associa-</cell><cell>http://www.aerztekammer.</cell><cell>Postgraduate Training Course for</cell><cell>German</cell></row><row><cell></cell><cell>tion Austria</cell><cell>at/veranstaltungen</cell><cell>Medical Doctors in Geriatric Medi-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>cine</cell><cell></cell></row><row><cell>Belgium</cell><cell>European Academy of</cell><cell>http://eama.eu</cell><cell>Leadership programme for academic</cell><cell>English</cell></row><row><cell></cell><cell>Aging (EAMA)</cell><cell></cell><cell>geriatricians</cell><cell></cell></row><row><cell>France</cell><cell>Languedoc Roussillon</cell><cell>http://reseau-idefi-2015.</cell><cell>Trans Innov Longévité: Trans-disci-</cell><cell>French</cell></row><row><cell></cell><cell>(16-18)</cell><cell>strikingly.com</cell><cell>plinary, multisectoral, private-public</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>partnership to train and coach on</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>frailty, ageing and independent living</cell><cell></cell></row><row><cell>Portugal</cell><cell>Ageing@Coimbra</cell><cell>http://www.ed.uc.pt/educ/</cell><cell>Distance Learning Course for Care</cell><cell>Portuguese</cell></row><row><cell></cell><cell></cell><cell>cursoid=96</cell><cell>Providers and the general public</cell><cell></cell></row><row><cell>UK</cell><cell>British Geriatric Society</cell><cell>http://www.bgs.org</cell><cell>Spring Postgraduate training course,</cell><cell>English</cell></row><row><cell></cell><cell></cell><cell></cell><cell>geriatric medicine, Edinburgh</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Scotland</cell><cell></cell></row><row><cell>UK</cell><cell>University of Oxford</cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>http://www.oxford.edu.</s><s>Onsite training courses English</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc><div><p><s>Contribution to the Scaling Up Strategy of the EIP on AHA: The proposal includes projects already developed in six European countries and is going to include organizations based in two more countries.</s><s>The objective of the proposal is to represent all European Regions.</s></p></div></figDesc><table><row><cell>Expected Outcomes / Contribution to MAFEIP</cell></row><row><cell>1-Community-based programmes should reduce mortality,</cell></row><row><cell>hospitalization and institutionalization rates in order to</cell></row><row><cell>improve QOL in the elderly.</cell></row><row><cell>2-The proposal will assess the capacity of different</cell></row><row><cell>interventions aimed to strengthen community-based health</cell></row><row><cell>and social care programmes and reduce the work load on</cell></row><row><cell>hospitals and residential Long Term Care services that are</cell></row><row><cell>much more expensive.</cell></row><row><cell>3-Impact on Growth and Jobs: strengthening community-based</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc><div><p><s>All CRDs impact QOL severely across the life cycle.</s><s>AIRWAYS ICPs is likely to have a major impact in seniors.</s><s>2-Novel care pathways including self-care, health and social carers that are patient-centered are required and represent one of the major objectives of AIRWAYS ICPs.</s><s>Better knowledge of the patterns of multimorbidity in CRDs and the characteristics of health care use.</s></p></div></figDesc><table><row><cell>Specific objectives</cell></row><row><cell>1-Promotion of AHA: Fit at work with rhinitis: Rhinitis</cell></row><row><cell>impacts work productivity more than diabetes, hypertension</cell></row><row><cell>or asthma. In Europe, work productivity costs due to rhinitis</cell></row><row><cell>are over 30 B€ yearly. The control of rhinitis by treatment</cell></row><row><cell>improves work productivity (40). This project includes care</cell></row><row><cell>pathways and should be a pilot for other common chronic</cell></row><row><cell>diseases.</cell></row><row><cell>2-Ageing well with rare paediatric diseases (e.g. cystic fibrosis</cell></row><row><cell>(CF) or bronchopulmonary dysplasia): The transition</cell></row><row><cell>between paediatrics, adult medicine and geriatrics is a key</cell></row><row><cell>issue for AHA in this severe genetic disease. The model of</cell></row><row><cell>CF can be deployed to other rare diseases (41).</cell></row><row><cell>3-Understanding, promoting health and controlling CRDs</cell></row><row><cell>across the life cycle for AHA (36) following the Polish (11,</cell></row><row><cell>42) and Cyprus priorities of the EU Council (43).</cell></row><row><cell>4-Understanding CRDs in elderly people: Care pathways</cell></row><row><cell>for airway diseases (rhinitis, asthma and COPD) and</cell></row><row><cell>their multimorbidities in elderly people need to identify</cell></row><row><cell>prioritized questions and use ICT tools (44, 45). Public</cell></row><row><cell>health initiatives are needed for the early identification of</cell></row><row><cell>those presenting in a pharmacy to purchase treatment.</cell></row><row><cell>5-Multimorbidity in CRDs. To describe the clinical profile of</cell></row><row><cell>patients with CRDs, the patterns of multimorbidity, and the</cell></row><row><cell>use of health services in this group of patients based on the</cell></row><row><cell>EpiChron cohort study (1.3M inhabitants).</cell></row><row><cell>6-Integrated care pathways for rhinitis across the life cycle</cell></row><row><cell>and remote monitoring with a specific focus on seniors (44,</cell></row><row><cell>45).</cell></row><row><cell>7-Interactions between chronic respiratory diseases and frailty</cell></row><row><cell>8-Polymedication: In CRDs, and particularly in COPD,</cell></row><row><cell>patient adherence is far from perfect. Most often, patients</cell></row><row><cell>discontinue their treatment very soon after its initiation.</cell></row><row><cell>Polymedication has profound medical and economical</cell></row><row><cell>consequences.</cell></row><row><cell>9-Societal problems in CRDs will be initially tackled with the</cell></row><row><cell>CARSAT (Caisse d'Assurance Retraite et Santé au Travail,</cell></row><row><cell>Social Security, France) (4, 18) and scaled up to EU regions</cell></row><row><cell>using the ICT tool on AHA (46-48).</cell></row><row><cell>10-Scaling up strategy, education, coaching and training</cell></row><row><cell>(EUFOREA).</cell></row><row><cell>Contribution to the Scaling Up Strategy of the EIP on AHA:</cell></row><row><cell>AIRWAYS ICPs is currently deployed in 25 EU countries with</cell></row><row><cell>national coordinations.</cell></row><row><cell>Expected Outcomes / Contribution to MAFEIP</cell></row><row><cell>1-</cell></row></table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Support for the EIP on AHA Scaling up strategy</head><p><s>The Scaling Up Strategy will follow the 5-step approach that has been proposed by the EIP on AHA and that has already been applied to AIRWAYS ICPs ((https://ec.europa.eu/</s><s>research/innovation-union/pdf/active-healthy-ageing/scaling_ up_strategy.pdf,</s><s><ref type="bibr">Bousquet et al, submitted)</ref>.</s></p><p><s>An up-scaling strategy is multidimensional and an accurate, appropriate and complete execution of each step is necessary to enable rigorous and systematic fulfilment of subsequent steps in the up-scaling process.</s><s>As an example, up-scaling the IKINÄ (THL National Falls Prevention Initiative) guideline for fall prevention by THL (Terveyden ja Hyvinvoinnin Laitos, National Institute for Health and Welfare, Finland) in Finland (49) may be proposed.</s><s>WHO's ExpandNet guides <ref type="bibr" target="#b66">(50)</ref> to up-scaling may provide potential additions to the Scaling-up Strategy of the EIP on AHA's.</s></p><p><s>The dissemination was proposed to be carried out using the same model as previous B3 AG and/or AIRWAYS ICPs meetings <ref type="bibr" target="#b52">(36,</ref><ref type="bibr" target="#b55">39,</ref><ref type="bibr" target="#b59">43,</ref><ref type="bibr" target="#b62">(46)</ref><ref type="bibr" target="#b63">(47)</ref><ref type="bibr" target="#b64">(48)</ref><ref type="bibr" target="#b67">(51)</ref><ref type="bibr" target="#b69">(52)</ref><ref type="bibr" target="#b70">(53)</ref><ref type="bibr" target="#b71">(54)</ref><ref type="bibr" target="#b72">(55)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Monitoring of activities carried out within the synergies</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MAFEIP</head><p><s>Monitoring the activities carried out within the EIP on AHA needs a flexible and consistent approach to estimate health and economic impacts across interventions and commitments.</s><s>A generic and flexible web-based monitoring and assessment tool has been developed.</s><s>The MAFEIP tool estimates health and economic outcomes in terms of incremental changes in Quality Adjusted Life Years (QALYs) as well as health and social care utilisation.</s><s>The MAFEIP-tool can provide an early assessment of the likelihood that interventions will achieve the anticipated impact.</s><s>It can also identify what drives the effectiveness or efficiency of interventions to guide further refinement, design upgrades and evaluation <ref type="bibr" target="#b16">(2,</ref><ref type="bibr" target="#b17">3)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AHA operative questionnaire</head><p><s>A core operational definition of AHA is needed to conduct comparisons <ref type="bibr" target="#b73">(56)</ref>.</s><s>A conceptual AHA framework proposed by the RSCN includes several items such as functioning (individual capability and underlying body systems, wellbeing, activities and participation, and diseases (including non-communicable diseases, frailty, mental and oral health disorders) <ref type="bibr" target="#b62">(46,</ref><ref type="bibr" target="#b63">47)</ref>.</s><s>The instruments include core and optional domains/instruments depending on the needs and questions <ref type="bibr" target="#b64">(48)</ref>.</s><s>A major common domain is function as measured by the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) that can be used across all diseases and healthy individuals.</s><s>It covers many of the AHA dimensions proposed by the RSCN.</s><s>However, WHODAS-2.0</s><s>does not include all dimensions proposed for AHA assessment.</s><s>The second common domain is Health-Related QOL (HRQL).</s><s>EQ-5D is one of the QALY measurements and the AHA questionnaire is therefore interoperable with MAFEIP.</s><s>The instrument is translated and culturally validated for most EU countries and will be digitalized in the first quarter of 2016.</s><s>A report of the AHA questionnaire in the form of a spider diagramme will facilitate usual comparisons across individuals and groups of interest <ref type="bibr" target="#b73">(56)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Other tools</head><p><s>Assessment scales, as information entities, are not often equipped with a rigorous typing of data.</s><s>This disables the gap between logic and guidelines, not only in geriatric assessment (57) but also within municipal and regional decisionmaking in elderly care.</s><s>Logic is, on the one hand, a carrier of information, and, on the other hand, it includes a mechanism for rigorous logical inference which underlies decisionmaking.</s><s>Gerontological conditions and circumstances are about information and knowledge, and gerontological data can be properly typed to open up possibilities e.g. for comparative studies and development of regional and national repositories involving gerontological data and information <ref type="bibr" target="#b75">(58)</ref>.</s></p><p><s>The information structure representation of nomenclatures</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">EFA European Federation of Allergy and Airways Diseases Patients&apos; Associations</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">K</forename><surname>London</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Information Management</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Directions régionales de la jeunesse, des sports et de la cohésion sociale (DRJSCS)</title>
	</analytic>
	<monogr>
		<title level="m">CIU-Santé (Centre d&apos;Innovation et d&apos;Usages en Santé)</title>
				<meeting><address><addrLine>Montpellier, France; Nice, France; Montpellier, France; Montpellier, France; Porto, Portugal; Montpellier, France; National Research Council, Neuroscience Institute, Padova, Italy; Imperial College London, UK; Odense, Denmark; Stockholm, Sweden; Suresnes Université Versailles Saint-Quentin; Toulouse, France</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">117</biblScope>
		</imprint>
		<respStmt>
			<orgName>Department of Rheumotology, Universityhospital ; UCIBIO, Department of Biological Sciences, Faculty of Pharmacy, University of Porto ; Department of Dermatology and Allergy Centre, Odense University Hospital ; The Centre for Allergy Research, The Institute of Environmental Medicine</orgName>
		</respStmt>
	</monogr>
	<note>Rangueil-Larrey Hospital. Respiratory Diseases Department</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">University Clinic of Pulmology and Allergy, Medical Faculty Skopje, R Macedonia; 131. Guy&apos;s and st Thomas&apos; NHS Trust</title>
	</analytic>
	<monogr>
		<title level="j">Global Allergy and Asthma Platform GAAPP</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<date type="published" when="1130">Altgasse 8-10, 1130</date>
		</imprint>
		<respStmt>
			<orgName>Service de physiologie respiratoire, Hôpital Cochin, Université Paris-Descartes, Assistance publique-Hôpitaux de ; University Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit ; Vilnius University</orgName>
		</respStmt>
	</monogr>
	<note>Medical Faculty</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">140. ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), IMIM (Hospital del Mar Research Institute)</title>
				<meeting><address><addrLine>Porto, Portugal; Portugal; Tbilisi, Georgia; Barcelona, Spain; Bilbao, Spain; Turkey</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">139</biblScope>
		</imprint>
		<respStmt>
			<orgName>Center for research in health technologies and information systems-CINTESIS, Allergy Unit, Instituto CUF Porto e Hospital CUF Porto ; Health Information and Decision Sciences Department -CIDES, Faculdade de Medicina, Universidade do Porto ; University of Deusto ; Department of Pulmonary Diseases, Istanbul University</orgName>
		</respStmt>
	</monogr>
	<note>Cerrahpasa Faculty of Medicine</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Department of Respiratory Diseases</title>
	</analytic>
	<monogr>
		<title level="j">Resident Medical Specialist on Medicine Mater Dei Hospital</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
		</imprint>
		<respStmt>
			<orgName>Instituto de Salud Carlos III</orgName>
		</respStmt>
	</monogr>
	<note>Agence Régionale de Santé</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m">Hôpital Bicêtre; Inserm UMR_S999</title>
				<meeting><address><addrLine>Montpellier, France; Birmingham, UK; Le Kremlin Bicêtre, Franc; Plymouth, UK; Imperial College</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">147</biblScope>
		</imprint>
		<respStmt>
			<orgName>Aston Research Centre for Healthy Ageing, Aston University ; Université Paris-Sud; Service de Pneumologie ; School of Psychology, Plymouth University ; Airway Disease Infection Section, National Heart and Lung Institute</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">MRC &amp; Asthma UK Centre in Allergic Mechanisms of Asthma</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Centre de l&apos;Asthme et des Allergies Hôpital d&apos;Enfants Armand-Trousseau</title>
	</analytic>
	<monogr>
		<title level="j">APHP</title>
		<imprint/>
	</monogr>
	<note>Allergology department</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Institut Pierre Louis d&apos;Epidémiologie et de Santé Publique</title>
	</analytic>
	<monogr>
		<title level="m">Equipe EPAR, F-75013</title>
				<meeting><address><addrLine>Paris, France; Poland</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page">153</biblScope>
		</imprint>
		<respStmt>
			<orgName>Sorbonne Universités, UPMC Univ Paris 06 ; Department of Clinical Immunology, Wrocław Medical University</orgName>
		</respStmt>
	</monogr>
	<note>UMR_S 1136</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Beatrix Children&apos;s Hospital, Department of Pediatric Pulmonology and Pediatric Allergology</title>
	</analytic>
	<monogr>
		<title level="j">Ukrainina Medical Stomatological Academy</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
		</imprint>
		<respStmt>
			<orgName>National Research Center, Institute of Immunology, Federal Medicobiological Agency, Laboratory of Molecular immunology ; Hacettepe University School of Medicine ; Hacettepe University, School of Medicine, Department of Chest Diseases ; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases ; Multimedia &amp; Computer Architecture Research Center, Dept of Control and Computer Engineering, Faculty of Electrical Engineering and Computing, University of ; Department of Immunology, Rheumatology and Allergy, Medical University of Lodz ; University of Groningen, University Medical Center Groningen ; Department of Geriatrics, Healthy Ageing Research Centre, Medical University of Lodz ; Barlicki University Hospital, Medical University of Lodz</orgName>
		</respStmt>
	</monogr>
	<note>Asthma and Allergy</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Department of Public health and health products</title>
	</analytic>
	<monogr>
		<title level="j">Fondazione IRCCS Ca&apos; Granda, Ospedale Maggiore Policlinico &amp; Department of Clinical Sciences and Community Health</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<date type="published" when="1087">UMR1087and CNR 6291</date>
			<publisher>Croatian Pulmonary Society</publisher>
		</imprint>
		<respStmt>
			<orgName>Clinic of infectious, chest diseases, dermatology and allergology, Vilnius University ; University of Edinburgh, UK; 167. University of Nantes, Service de Pneumologie, UMR INSERM ; Department of Respiratory Medicine, University of Bratislava ; Centre for Occupational and Environmental Medicine ; National Institute of Pneumology M Nasta ; Faculty of Medicine, University of Belgrade ; Paris Descartes University-Sorbonne Paris Cité</orgName>
		</respStmt>
	</monogr>
	<note>The Queen&apos;s Medical Research Institute. EA 4064 and Paris municipal Department of social action, childhood, and health</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Sociedade Portuguesa de Alergologia e Imunologia Clínica</title>
	</analytic>
	<monogr>
		<title level="j">Immunoallergy. Department, Hospital CUF-Descobertas</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
		</imprint>
		<respStmt>
			<orgName>Paris municipal Department of social action, childhood, and health ; Academic Head of Dept and Professor of Medicine University of Malta, Deputy Dean Faculty of Medicine and Surgery University of Medicine ; Institute of Health Carlos III (Nursing and Health Care Research Unit</orgName>
		</respStmt>
	</monogr>
	<note>Lead Respiratory Physician Mater Dei Hospital Malta</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children&apos;s Hospital, University of Manchester, Manchester M13 9WL, UK Allergy Department, 2nd Pediatric Clinic, Athens General Children&apos;s Hospital «P&amp;A Kyriakou</title>
	</analytic>
	<monogr>
		<title level="m">Greece; 191. NHS Unit for Hemoglobinopathies prevention and treatment, Laikon general Hospital</title>
				<meeting><address><addrLine>Germany; Barcelona, Catalonia, Spain; University of Valencia, Spain; Budapest, Hungary; Montpellier, France; Faro, Portugal; Genoa, Italy; Pilsen, Czech Republic; Athens; Athens, Greece; Lattes, France; Montpellier, France; Montpellier, France</addrLine></address></meeting>
		<imprint>
			<date>11527</date>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page">34000</biblScope>
		</imprint>
		<respStmt>
			<orgName>Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne ; ENT Department, Hospital Clínic, IDIBAPS. CIBERES ; EA4556 Epsylon, Université Montpellier 1 ; University of Algarve (School of Health ; Charles University in Prague ; » University of Athens ; L&apos;ETAPE -Pôle Autonomie Santé, CCAS de Lattes</orgName>
		</respStmt>
	</monogr>
	<note>Régime social des indépendants (RSI)</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inserm ResearchUnit 710, Montpellier and Ecole Pratique des Hautes Etudes (EPHE)</title>
	</analytic>
	<monogr>
		<title level="j">Child. Health, Queen&apos;s University Belfast &amp; Royal Belfast Hospital for Sick Children</title>
		<imprint>
			<biblScope unit="volume">197</biblScope>
			<date type="published" when="0200">199. 200</date>
		</imprint>
		<respStmt>
			<orgName>Children&apos;s Hospital Srebrnjak, Zagreb, School of Medicine, University J.J. Strossmayer, Osijek, Croatia; 196. Clinic. of Allergy and Asthma, Alexander&apos;s University Hospital ; University of Groningen, University Medical Center Groningen, Department of Pulmonary Medicine and Tuberculosis, GRIAC Research institute ; University of Aberdeen ; Polibienestar Research Institute, University of Valencia ; Hôpitaux Universitaires ; Department of Cardiology, Montpellier University Hospital ; Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh ; ITACA -Universitat Politècnica de Valéncia, Spain; 209. Allergy Unit, Department of Dermatology, University Hospital of Zurich ; Cochrane Germany, Medical Center, University of Freiburg ; CHU Rangueil-Larrey ; The University of Edinburgh ; Department of Thoracic Medicine, University Hospital of Heraklion ; Department of Otorhinolaryngology, Akershun University Hospital ; Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht, University of Utrecht ; Faculty of Pharmacy, University of Porto</orgName>
		</respStmt>
	</monogr>
	<note>Euro-Asian respiratory Society</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Cyprus International Institute for Environmental &amp; Public Health in Association with Harvard School of Public Health</title>
	</analytic>
	<monogr>
		<title level="m">Dpt of Molecular Medicine and Medical Biotecnology; GENS Foundation, Italy; 225. Division of Allergy and Clinical Immunology</title>
				<editor>
			<persName><surname>Unité De Pharmacoépidémiologie</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Cnrs -Université Claude Bernard</forename><surname>Chu-Lyon -Ur 5558</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">France</forename><surname>Lyon</surname></persName>
		</editor>
		<meeting><address><addrLine>Montpellier, France; Salerno, Italy; Barcelona, Spain; Finland; Stockholm; Bari, Italy; Bilbao, Spain; Arcispedale SMaria Nuova/IRCCS, Research Hospital, Reggio Emilia, Italy; Pisa, Italy; Germany; Newcastle, UK; Limassol, Cyprus; Nicosia, Cyprus; Golnik, Slovenia; Funka, Sweden</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">222</biblScope>
			<biblScope unit="page">34295</biblScope>
		</imprint>
		<respStmt>
			<orgName>Academic Medical Centre, University of Amsterdam ; Centre of Pneumology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; 223. University Hospital ; University Federico II of Naples ; University of Salerno ; University of Turku ; University of Bari Medical School ; Dept of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf ; North of England EU Health Partnership ; Cyprus University of Technology ; University of Southampton; 238. University Clinic of Respiratory and Allergic Diseases</orgName>
		</respStmt>
	</monogr>
	<note>Social Sciences. Project Officer, EC-CNECT-H2, European Commission, Brussels, Belgium. Corresponding author: Professor Jean Bousquet, CHRU, 371 Avenue du Doyen Gaston Giraud</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Standberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Crooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Iakovidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gomez</surname></persName>
		</author>
		<idno>+33 611 42 88 47</idno>
	</analytic>
	<monogr>
		<title level="j">Montpellier Cedex</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="361" to="362" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>Eur Geriatr Med</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Development of a web-based tool for the assessment of health and economic outcomes of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Boehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Steuten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abadie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl 3:S4</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Early Health Economic Assessment in Innovation Partnerships: Lessons from the European Innovation Partnership on Active and Healthy Ageing</title>
		<author>
			<persName><forename type="first">G</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Steuten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pecchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boehler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Value Health</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">A726</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Active and Healthy Ageing: From health prevention to personal care. CARSAT-MACVIA 7 meeting</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nogues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Millot-Keurinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iglesia-Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alonso-Bouzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bewick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bialoszewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Geriatr Med</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts</title>
		<author>
			<persName><forename type="first">T</forename><surname>Podar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Solntsev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reunanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Urbonaite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zalinkevicius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karvonen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="290" to="294" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Rate and prediction of infection in children with diabetic ketoacidosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Flood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Chiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="270" to="273" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Compliance with blood glucose monitoring in children with type 1 diabetes mellitus</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Endres</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1022" to="1024" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Stigma, discrimination, empowerment and social networks: a preliminary investigation of their influence on subjective quality of life in a Swedish sample</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wentz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bjorkman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Soc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="47" to="55" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effect of a structured diabetes education programme in primary care on hospitalizations and emergency department visits among people with Type 2 diabetes mellitus: results from the Patient Empowerment Programme</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Lam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabet Med</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Factors contributing to the subjective quality of life of the chronic mentally ill</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rosenfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Health Soc Behav</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="299" to="315" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union</title>
		<author>
			<persName><forename type="first">B</forename><surname>Samolinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fronczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kuna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Z</forename><surname>Bialoszewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="726" to="731" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Implementing a Community Empowerment Center to Build Capacity for Developing, Implementing, and Sustaining Interventions to Promote Community Health</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Smallwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Pitner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Sharpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hastie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Community Health</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1122" to="1129" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Patient empowerment as a component of health system reforms: rights, benefits and vested interests</title>
		<author>
			<persName><forename type="first">C</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gonzalez-Lorenzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Liberati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mosconi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intern Emerg Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="183" to="187" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m" type="main">Declaration and Programme of Action of the World Summit for Social Development, Draft Declaration, art</title>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">26</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Leveraging E-government at a Time of Financial and Economic Crisis&quot;: Chapter 5 Citizen empowerment and inclusion</title>
		<imprint>
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
	<note>United Nations E-Government Survey</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Living lab MACVIA-LR Equilibre et Prévention des Chutes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Blain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Leglise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Bernard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dupeyron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pastor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Strubel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="s">Presse Med</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Site de Référence MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc Roussillon) et Institut Euricap (European Institute fro Chronic Diseases, Ageing and Handicap)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bourret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Camuzat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Augé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Domy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bringer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Presse Med</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>suppl):in press</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Living Lab Fragilité MACVIA-LR</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nogues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jeandel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Touchon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Blain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leglise</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="s">Presse Med</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<idno type="DOI">10.2777/46253</idno>
		<title level="m">Options for Strengthening Responsible Research and Innovation -Report of the Expert Group on the State of Art in Europe on Responsible Research and Innovation</title>
				<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Responsible innovation: a pilot study with the U.K. Engineering and Physical Sciences Research Council</title>
		<author>
			<persName><forename type="first">R</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goldberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Risk Anal</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1699" to="1707" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Expert Group on Policy Indicators for Responsible Innovation. Indicators for promoting and monitoring Responsible Research and Innovation Report from the Expert Group on Policy Indicators</title>
		<author>
			<persName><forename type="first">R</forename><surname>Strand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Revuelta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stagl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paula</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<publisher>Luxembourg: Publications Office of the European Union</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title level="m" type="main">Living Lab Falls-MACVIA-LR: The falls prevention initiative of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA</title>
		<author>
			<persName><forename type="first">H</forename><surname>Blain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abecassis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Adnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Alomène</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Amouyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bardy</surname></persName>
		</author>
		<imprint>
			<pubPlace>Languedoc Roussillon</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Eur Geriatr Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="416" to="425" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The patient who falls: «It&apos;s always a trade-off</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Tinetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="258" to="266" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Implementation of multifactorial interventions for fall and fracture prevention</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Robertson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Age Ageing</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="60" to="64" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Fall prevention: single or multiple interventions? Single interventions for fall prevention</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Robertson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="281" to="284" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cawston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maravic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fardellone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gauthier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kanis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Compston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Osteoporos</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="237" to="246" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Screening for markers of frailty and perceived risk of adverse outcomes using the Risk Instrument for Screening in the Community (RISC)</title>
		<author>
			<persName><forename type="first">R</forename><surname>O'caoimh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Svendrovski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Healy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>O'connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>'keeffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Geriatr</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">104</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults</title>
		<author>
			<persName><forename type="first">R</forename><surname>O'caoimh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cornally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Weathers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>O'sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Orfila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Maturitas</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="21" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Inequality in diabetes-related hospital admissions in England by socioeconomic deprivation and ethnicity: facility-based cross-sectional analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gilmour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shibuya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e0116689</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">A longitudinal examination of social participation, loneliness, and use of physician and hospital services</title>
		<author>
			<persName><forename type="first">N</forename><surname>Newall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcarthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">H</forename><surname>Menec</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Aging Health</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="500" to="518" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">A Community-Based, Technology-Supported Health Service for Detecting and Preventing Frailty among Older Adults: A Participatory Design Development Process</title>
		<author>
			<persName><forename type="first">L</forename><surname>Van Velsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Illario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jansen-Kosterink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Crola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Somma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Colao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Aging Res</title>
		<imprint>
			<biblScope unit="page">216084</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Impact of the Community-Based Active Monitoring Program on the Long Term Care Services Use and In-Patient Admissions of the Over-74 Population</title>
		<author>
			<persName><forename type="first">M</forename><surname>Marazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inzerilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Madaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Palombi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scarcella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Orlando</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Ageing Res</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="187" to="194" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Perceived Risk of Mental Health Problems in Primary Care</title>
		<author>
			<persName><forename type="first">C</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Azevedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duarte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>O'caoimh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Aging Neurosci</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">212</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title level="m" type="main">Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Böhmdorfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Frühwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roller-Wirnsberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dovjak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dückelmann-Hofer</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Wien Klin Wochenschr</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="160" to="169" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<title level="m" type="main">Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khaltaev</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>ISBN 978 92 4 156346 8. 2007:148 pages</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Developmental determinants in non-communicable chronic diseases and ageing</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Berkouk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gergen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Antunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Auge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="595" to="597" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Integrated care pathways for airway diseases (AIRWAYS-ICPs)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Addis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Adcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Agusti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alonso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="304" to="323" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">MACVIA-LR (France) case study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mercier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Avignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bourret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Camuzat</surname></persName>
		</author>
		<idno>EUR 27150 EN</idno>
		<ptr target="https://ec.europa.eu/jrc" />
	</analytic>
	<monogr>
		<title level="m">Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS3). JRC94487. Luxembourg: Publications Office of the European Union: JRC (Joint Research Centre ) Science and policy report</title>
				<editor>
			<persName><forename type="first">F</forename><surname>Abadie</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="report_type">Report</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">The fight against chronic respiratory diseases in the elderly: the European Innovation Partnership on Active and Healthy Aging and beyond</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thorac Dis</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="108" to="110" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA 2 LEN and AllerGen)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khaltaev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Denburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Fokkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Togias</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">86</biblScope>
			<biblScope unit="page" from="8" to="160" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">A model for active and healthy ageing with a rare genetic disease: cystic fibrosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Chiron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Caimmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Valiulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Durieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tejedor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Cam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="714" to="719" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Council of the European Union conclusions on chronic respiratory diseases in children</title>
		<author>
			<persName><forename type="first">B</forename><surname>Samolinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fronczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wlodarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">379</biblScope>
			<biblScope unit="issue">9822</biblScope>
			<biblScope unit="page" from="e45" to="46" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Tanasescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Camuzat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Blasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="555" to="561" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bourret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">T C</forename><surname>Bedbrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">P D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Hosp Health Serv</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="36" to="39" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schunemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fonseca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Samolinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Canonica</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1372" to="1392" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Operational definition of active and healthy ageing (AHA): Framework concensus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kuh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bewick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Strandberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pengelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Health Aging</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="955" to="960" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Operational definition of active and healthy ageing (AHA): Report of the meeting held in Montpellier</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kuh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bewick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Strandberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pengelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Geriatr Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="196" to="200" />
			<date type="published" when="2015-10-21">October 21. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Operational definition of active and healthy ageing (AHA): The European Innovation Partnership (EIP) on AHA Reference Site questionnaire</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Malva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nogues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rodriguez-Mañas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vellas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Farrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1020" to="1026" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Guideline for development and implementation of evidence based falls prevention and best practices</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pajala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Finnish: Kehitä ja johda kaatumisten ehkäisyä. Opas toimintakäytäntöjen implementointiin</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<monogr>
		<title level="m" type="main">Practical guidance for scaling up health service innovations</title>
		<ptr target="http://whqlibdoc.who.int/publications/2009/9789241598521_eng.pdf" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hajjam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Piette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jean-Bart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wlosik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Robine</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>The French reference sites of the European Innovation Partnership on active and healthy ageing</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Presse Med</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1558" to="1561" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Portugal at the cross road of international chronic respiratory programmes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rosado</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barbara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Correira</forename><surname>Da Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fonseca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Pereira</forename><surname>Miguel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Port Pneumol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="230" to="232" />
			<date type="published" when="2006">2006. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/ AIRWAYS ICPs Meeting at the Ministry of Health and Care Services</title>
		<author>
			<persName><forename type="first">Lodrup</forename><surname>Carlsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Haahtela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Carlsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bjerke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wickman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="57" to="64" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<monogr>
		<title level="m" type="main">European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Fokkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pietikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Borrelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015-10-14">October 14. 2015. 2015</date>
			<publisher>Rhinology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Fokkens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pietikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Borrelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium</title>
				<imprint>
			<date type="published" when="2015-10-14">October 14. 2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Operational definition of active and healthy ageing: Roadmap from concept to change of management</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Malva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Maturitas</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="3" to="4" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Rating scales in old age psychiatry</title>
		<author>
			<persName><forename type="first">A</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lawlor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Craig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="161" to="167" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">The logic of geriatrics</title>
		<author>
			<persName><forename type="first">P</forename><surname>Eklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Immonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Petäkoski-Hult</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Similä</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Health Ageing</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S305" to="306" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Fuzzy terms</title>
		<author>
			<persName><forename type="first">P</forename><surname>Eklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Galán</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Helgesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kortelainen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Fuzzy. Sets Syst</title>
		<imprint>
			<biblScope unit="volume">256</biblScope>
			<biblScope unit="page" from="211" to="235" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<monogr>
		<title level="m" type="main">Lative Logic Accomodating the WHO Family of International Classifications</title>
		<author>
			<persName><forename type="first">P</forename><surname>Eklund</surname></persName>
		</author>
		<editor>Cruz-Cunha M, Miranda I</editor>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>Encyclopedia of E-Health and Telemedicine IGI Global. in press</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
